156 related articles for article (PubMed ID: 37001708)
1. Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins.
Tae HS; Adams DJ
Pharmacol Res; 2023 May; 191():106747. PubMed ID: 37001708
[TBL] [Abstract][Full Text] [Related]
2. α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors.
Giribaldi J; Dutertre S
Neurosci Lett; 2018 Jul; 679():24-34. PubMed ID: 29199094
[TBL] [Abstract][Full Text] [Related]
3. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors.
Tae HS; Gao B; Jin AH; Alewood PF; Adams DJ
Biochem Pharmacol; 2021 Aug; 190():114638. PubMed ID: 34062129
[TBL] [Abstract][Full Text] [Related]
4. α-Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes.
Ning H; Huang B; Tae HS; Liu Z; Yu S; Li L; Zhang L; Adams DJ; Guo C; Dai Q
J Neurochem; 2021 Oct; 159(1):90-100. PubMed ID: 34008858
[TBL] [Abstract][Full Text] [Related]
5. alpha-Conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads.
Dutton JL; Craik DJ
Curr Med Chem; 2001 Mar; 8(4):327-44. PubMed ID: 11172693
[TBL] [Abstract][Full Text] [Related]
6. Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails.
Abraham N; Lewis RJ
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29899286
[TBL] [Abstract][Full Text] [Related]
7. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
[TBL] [Abstract][Full Text] [Related]
9. Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives.
Armishaw C; Jensen AA; Balle T; Clark RJ; Harpsøe K; Skonberg C; Liljefors T; Strømgaard K
J Biol Chem; 2009 Apr; 284(14):9498-512. PubMed ID: 19131337
[TBL] [Abstract][Full Text] [Related]
10. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.
Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA
J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032
[TBL] [Abstract][Full Text] [Related]
11. Structure-Function Elucidation of a New α-Conotoxin, MilIA, from
Peigneur S; Devi P; Seldeslachts A; Ravichandran S; Quinton L; Tytgat J
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527432
[TBL] [Abstract][Full Text] [Related]
12. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Activity of Novel α-Conotoxins Derived from Endemic Polynesian Cone Snails.
Souf YM; Lokaj G; Kuruva V; Saed Y; Raviglione D; Brik A; Nicke A; Inguimbert N; Dutertre S
Mar Drugs; 2023 Jun; 21(6):. PubMed ID: 37367681
[TBL] [Abstract][Full Text] [Related]
14. α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.
Cuny H; Yu R; Tae HS; Kompella SN; Adams DJ
Br J Pharmacol; 2018 Jun; 175(11):1855-1868. PubMed ID: 28477355
[TBL] [Abstract][Full Text] [Related]
15. A short framework-III (mini-M-2) conotoxin from the venom of a vermivorous species, Conus archon, inhibits human neuronal nicotinic acetylcholine receptors.
Hernández-Sámano AC; Falcón A; Zamudio F; Michel-Morfín JE; Landa-Jaime V; López-Vera E; Jeziorski MC; Aguilar MB
Peptides; 2022 Jul; 153():170785. PubMed ID: 35307452
[TBL] [Abstract][Full Text] [Related]
16. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
Li X; Tae HS; Chu Y; Jiang T; Adams DJ; Yu R
Pharmacol Ther; 2021 Jun; 222():107792. PubMed ID: 33309557
[TBL] [Abstract][Full Text] [Related]
17. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
18. The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.
Wu RJ; Wang L; Xiang H
Curr Top Med Chem; 2015; 16(2):156-69. PubMed ID: 26126912
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analogues.
Millard EL; Nevin ST; Loughnan ML; Nicke A; Clark RJ; Alewood PF; Lewis RJ; Adams DJ; Craik DJ; Daly NL
J Biol Chem; 2009 Feb; 284(8):4944-51. PubMed ID: 19098004
[TBL] [Abstract][Full Text] [Related]
20. Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins.
Kudryavtsev D; Shelukhina I; Vulfius C; Makarieva T; Stonik V; Zhmak M; Ivanov I; Kasheverov I; Utkin Y; Tsetlin V
Toxins (Basel); 2015 May; 7(5):1683-701. PubMed ID: 26008231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
